This pattern is also seen in CD133+ glioblastoma cells, where the overexpression of insulin-like growth factor 2 mRNA-binding protein 2 (IMP2) modulates mitochondrial dynamics and stemness markers such as CD133, SOX2, and NANOG [75]. This evidence concerns the gene IGF2BP2 and glioblastoma.